ArticleScientific reports2025

A cost-utility analysis of adding SGLT2 inhibitors for the management of type 2 diabetes with chronic kidney disease in Thailand.

Natthakan Chitpim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.